In-stent restenosis has been significantly reduced by utilization of drug eluting stents.
药物涂层支架的应用显著降低了支架内再狭窄的发生。
Attention has recently been focused on late stent thrombosis related to the use of drug-eluting stents.
但最近药物支架晚期血栓的问题倍受关注。
Conclusion Drug-eluting stent implantation can decrease the rate of restenosis significantly in coronary intervention.
结论药物涂层支架置入可显著降低冠脉介入术后再狭窄率。
Increasingly doctors use what is called a drug-eluting stent. This kind has medicine on it that is released slowly over time.
医生使用一种叫做药物洗提的管状物日益增加，这种类型的管状物有药物在里面，随着时间的推移慢慢地释放。
The purpose of this article is to review the relevant preclinical and clinical data in the field of rapamycin eluting stent for the prevention of restenosis.
本文就目前雷帕霉素涂层支架在临床防治再狭窄研究的最新进展作一综述。
Conclusion Short-term and middle-term outcomes of treating bifurcation lesions with domestic and imported sirolimus-eluting stent techniques in patients is similar.
结论国产与进口雷帕霉素支架治疗分叉病变患者的早中期疗效相似。
OBJECTIVE: To investigate how to elevate the compatibility of drug-eluting stent in elderly cardiovascular disease from aspects of material and clinical application.
目的：从材料学及临床应用方面阐述如何提高老年心血管疾病中药物涂层支架的相容性。
This article reviews the clinical evidence and pathophysiological mechanisms of stent thrombosis of drug-eluting stent, especially the role of the stent itself in it.
现对药物涂层支架内血栓形成的相关临床证据和病理生理机制，特别是药物涂层支架本身在其中的作用进行综述。
OBJECTIVE: To understand the types and characteristics of anti-proliferative drug-eluting stent, and its effectiveness in clinical applications and problems to be solved.
目的：了解抗增殖作用药物涂层支架的种类和特点及其在临床应用中的有效性和亟待解决的问题。
The cost of drug eluting stents per person and cost of each drug eluting stent in imported stent group were significantly higher than those of domestic stent group (P<0.001).
进口支架组人均置入支架总费用和单个支架费用均显著高于国产支架组（P<0.001）；
Objective to investigate the effectiveness dose-effect relationships for inhibiting proliferation by Triptolide-eluting stent, and the safety of the Triptolide eluting stent.
目的研究雷公藤甲素涂层支架抑制新生内膜增殖的有效性、量效关系，并研究该支架的安全性。
Conclusion a better treatment for the patients with multi-vessel coronary disease, rapamycin-eluting stent implantation has the clinical effects comparable to those of the CABG.
结论雷帕霉素洗脱支架术治疗多支冠状动脉病变患者长期疗效与CABG相当，是治疗多支病变冠心病患者一种较好的方法。
The implantation of a drug-eluting stent is one of the main methods for treating coronary heart disease, but the occurrence of thrombogenesis after implantation remains a problem.
药物洗脱支架置入是目前治疗冠心病的主要方式，但血栓形成仍是目前关注的主要问题。
Objective To compare the clinical effects of rapamycin-eluting stent implantation and coronary artery bypass grafting (CABG) in treatment of the patients with multi-vessel coronary disease.
目的比较雷帕霉素洗脱支架术与冠状动脉旁路移植术(CABG)治疗多支冠状动脉病变的临床疗效。
Objective Compare drug-eluting stent (DES) to bare-metal stent(BMS) in prognosis on treating diffuse coronary lesions and analysis risk factor of treating complex and diffuse lesions in PCI.
目的比较冠心病患者弥漫病变采用药物洗脱支架和金属裸支架治疗的近期和远期预后，分析影响这类病变介入治疗预后的危险因素。
Objective to study the related factors and prognosis of rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
目的：探讨ST段抬高性心肌梗死患者经皮冠状动脉介入置入雷帕霉素药物洗脱支架内血栓形成的相关因素及预后。
A total of 804 patients who had successful sirolimus- or paclitaxel-eluting stent implantation were assessed for post-treatment platelet reactivity after a loading dose of 600 mg of clopidogrel.
总共804名成功植入西罗莫司或紫杉醇药物洗脱支架的病人，检查了他们在服用了600mg负荷计量的氯吡格雷之后的治疗后血小板活性。
Right now, we try to keep dual anti-platelet therapy going for up to one year in patients who have a drug-eluting stent because we are very concerned about the possibility of late-stent thrombosis.
目前，对于接受药物洗脱支架的患者，我们尝试维持双重抗血小板治疗在一年以上，因为我们非常关注晚期支架内血栓形成的可能性。
Right now, we try to keep dual anti-platelet therapy going for up to one year in patients who have a drug-eluting stent because we are very concerned about the possibility of late-stent thrombosis.
目前，对于接受药物洗脱支架的患者，我们尝试维持双重抗血小板治疗在一年以上，因为我们非常关注晚期支架内血栓形成的可能性。
应用推荐